Andrew L. Finn
2012
In 2012, Andrew L. Finn earned a total compensation of $495.1K as Executive VP of Product Development at BioDelivery Sciences International, a 25% increase compared to previous year.
Compensation breakdown
| Bonus | $87,900 |
|---|---|
| Option Awards | $73,684 |
| Salary | $296,785 |
| Other | $36,755 |
| Total | $495,124 |
Finn received $296.8K in salary, accounting for 60% of the total pay in 2012.
Finn also received $87.9K in bonus, $73.7K in option awards and $36.8K in other compensation.
Rankings
In 2012, Andrew L. Finn's compensation ranked 8,795th out of 11,487 executives tracked by ExecPay. In other words, Finn earned more than 23.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,795 out of 11,487 | 23rd |
Division Manufacturing | 3,207 out of 4,253 | 25th |
Major group Chemicals And Allied Products | 864 out of 1,198 | 28th |
Industry group Drugs | 635 out of 920 | 31st |
Industry Pharmaceutical Preparations | 493 out of 700 | 30th |
Source: SEC filing on June 12, 2013.
Finn's colleagues
We found four more compensation records of executives who worked with Andrew L. Finn at BioDelivery Sciences International in 2012.
2012
Mark Sirgo
BioDelivery Sciences International
Chief Executive Officer
2012
Mark SirgoPharmD
BioDelivery Sciences International
Chief Executive Officer
2012
James McNulty
BioDelivery Sciences International
Chief Financial Officer
2012
Andrew FinnPharmD
BioDelivery Sciences International